#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired ATTR amyloidosis Fallopian tube cancer Squamous cell carcinoma of the hypopharynx Soft tissue sarcoma Head and neck cancer Small for dates baby Congenital pseudarthrosis Multiple system atrophy Cognitive disorder Aicardi-Goutieres syndrome Myasthenia gravis Acute leukaemia Ependymoma B precursor type acute leukaemia Juvenile idiopathic arthritis More trials…

    Learn about Rare Diseases

    Pemphigoid – Life with Disease Phenylketonuria – Basic Information Primary immunodeficiency syndrome – Treatment Nephrotic syndrome – Diagnostics Atypical haemolytic uraemic syndrome Cholangitis sclerosing – Life with Disease VEXAS syndrome – Treatment Choroid melanoma – Treatment Piriformis syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imiglucerase Bio89-100 Specific Nucleic Acid Sna-Xfsa Hydroxi-Methionine Calcium Zinc Acetate Dihydrate Wt1 Lamp Mrna Dc Fluconazole Simeticone Tumor Necrosis Factor-Alpha Maralixibat Chloride Ecoo25B Retinol Acetate Cilastatin Sodium TAGRAXOFUSP Estradiol Gsk4011499 Dordaviprone RPTR-1-201 VTX-002 Calcium More therapies…

    Learn about Your Condition

    Infant sedation Syphilis Synovial sarcoma metastatic Hypogonadism male Amyloidosis Mastocytosis Skin neoplasm excision Follicular lymphoma stage IV Cervix carcinoma stage IV Frontotemporal dementia Actinic keratosis Premature rupture of membranes Rectal cancer stage II Breast neoplasm Lyme disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Dantrolene Sodium for Treating Darier Disease in Affected Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Keratosis follicular
    Investigated Drugs:
    • Dantrolene Sodium
    Sweden

  • Study of [18F]FAPI-74 PET/CT Imaging in Patients with Connective Tissue Disease at Risk of Lung Fibrosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • [18F]Fapi-74
    Italy

  • Study on the Effectiveness and Safety of Barzolvolimab for Patients with Chronic Inducible Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cold urticaria
    Investigated Drugs:
    • Barzolvolimab
    Bulgaria Germany Hungary Latvia Lithuania Poland +1

  • Study on Rezpegaldesleukin for Treating Severe Alopecia Areata in Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Rezpegaldesleukin
    Poland

  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Bulgaria Croatia Germany Hungary Italy Lithuania +4

  • Study on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Tralokinumab
    Belgium Czechia France Germany The Netherlands Poland +3
Previous Page
1 … 45 46 47 48 49 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!